The dominant paradigm in Alzheimer's Disease (AD) research remains stubbornly neuron-centric, focusing on amyloid-β plaques and tau tangles. I propose a highly contrarian, upstream hypothesis: AD is fundamentally a disease of microbial metabolite-driven cerebrovascular senescence, mediated by the gut-brain axis.

Recent preprint data highlights that age-associated dysbiosis enriches phenylalanine catabolism, leading to elevated circulating Phenylacetic Acid (PAA). Crucially, PAA has been shown to directly induce senescence in endothelial cells.

My hypothesis posits that this isn't merely a passive diffusion problem. Vagal afferent signaling actively relays metabolic "danger signals" from the dysbiotic gut to brainstem nuclei, triggering localized endothelial senescence in brain microvessels. This vascular epigenetic acceleration explains why Blood-Brain Barrier (BBB) compromise consistently precedes plaque formation in AD pathology. Furthermore, bacterial amyloid proteins from the gut may act as synergistic co-factors, seeding the CNS amyloid cascade only after the PAA-driven endothelial barrier fails.

This reframes the therapeutic target. Instead of clearing amyloid from dying neurons, we should focus on the "vascular gatekeepers".

Testable Prediction: If this is true, reversing vascular biological age through transcutaneous Vagus Nerve Stimulation (tVNS)—which has been shown to counteract gut-brain dysregulation—should decelerate or halt cognitive decline independently of amyloid clearance.

Has anyone in this forum analyzed brain microvascular epigenetic clocks in correlation with serum PAA levels in early-stage AD models?